The invention discloses a traditional-Chinese-
medicine compound prescription for reducing the
relapse rate of tumor patients and relates to the traditional-Chinese-
medicine compound prescription. The traditional-Chinese-
medicine compound prescription contains the following components in
mass by weight: 10-50g of radix salviae miltiorrhizae, 10-50g of
curcuma zedoary, 3-20g of radix pseudostellariae, 6-30g of poria cocos, 3-30g of
pinellia ternata, 3-30g of Ussuriensis Fritillary
Bulb, 3-50g of
oyster, 3-50g of lapis chloriti, 3-15g of radix aucklandiae, 3-30g of fried rice sprout and 3-30g of tuber fleeceflower stem. Proved by animal experiments, the traditional-Chinese-medicine compound prescription has the effects of obviously prolonging the life period with
cancer, reducing antagonistic leukocytes, promoting
cancer cell apoptosis, inhibiting proliferation of tumor
histopathology and the like for mice with
chemotherapy for the
solid transplanted tumor and the ascitic tumor of the
liver cancer; for all the patients after indications and operation
chemotherapy and the patients after pure
chemotherapy, the purposes of prolonging the life period, improving the living quality and reducing the
relapse rate can be achieved; the traditional-Chinese-medicine compound prescription is developed completely based on health-care products with China
health food approval number of Chinese herbal medicines for health-care foods; and as a long-term target, various dosage forms of
Chinese patent medicines with more obvious effects are developed.